These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10563741)

  • 1. Elevation of serum CA19-9 levels in benign diseases.
    Ito S; Gejyo F
    Intern Med; 1999 Nov; 38(11):840-1. PubMed ID: 10563741
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevation of serum and urinary carbohydrate antigen 19-9 in benign hydronephrosis.
    Aybek H; Aybek Z; Sinik Z; Demir S; Sancak B; Tuncay L
    Int J Urol; 2006 Nov; 13(11):1380-4. PubMed ID: 17083387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation of serum carbohydrate antigen 19-9 with benign hydronephrosis.
    Suzuki K; Muraishi O; Tokue A
    J Urol; 2002 Jan; 167(1):16-20. PubMed ID: 11743265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraordinarily elevated serum CA19-9 in a patient with posterior mediastinum cyst: a case report.
    Chen J; Liu Q; Ling Y; Yang H; Wen J; Luo K; Hu Y; Tan Z; Fu J
    Clin Chem Lab Med; 2017 Oct; 55(12):e279-e281. PubMed ID: 28672729
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of hydronephrosis with high level of serum Span-1 antigen and CA19-9].
    Kondoh K; Noguchi S; Shuin T; Masuda M; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1996 Jan; 42(1):51-3. PubMed ID: 8686585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice.
    Ng WW; Tong KJ; Tam TN; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased CA-19-9 caused by a splenic cyst: a rare differential diagnosis].
    Decker D; Bollmann R; Hirner A; Stratmann H
    Zentralbl Chir; 1998; 123(7):855-7. PubMed ID: 9746988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extraordinary high elevation of serum CA19-9 levels in an apparently healthy subject].
    Kaneko Y; Shibata Y; Nakamura H; Kuroda M; Nakazima T; Kasakura S
    Rinsho Byori; 1999 Oct; 47(10):943-8. PubMed ID: 10590668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA.
    Maestranzi S; Przemioslo R; Mitchell H; Sherwood RA
    Ann Clin Biochem; 1998 Jan; 35 ( Pt 1)():99-103. PubMed ID: 9463746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case Report and a Short Literature Review of Pulmonary Sequestration Showing Elevated Serum Levels of Carbohydrate Antigen 19-9.
    Dong J; Cai Y; Chen R; Du S; Chen Y; Shi K
    J Nippon Med Sch; 2015; 82(4):211-5. PubMed ID: 26328799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.
    Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG
    J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions.
    Marrelli D; Caruso S; Pedrazzani C; Neri A; Fernandes E; Marini M; Pinto E; Roviello F
    Am J Surg; 2009 Sep; 198(3):333-9. PubMed ID: 19375064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Superficial urothelial carcinoma of ureter with elevated serum CA19-9 and CEA].
    Kato S; Yasuda M; Nakano M; Ehara H; Ishihara T; Deguchi T; Sakata Y; Mori H; Shimokawa K
    Hinyokika Kiyo; 2004 Feb; 50(2):99-102. PubMed ID: 15101165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease.
    Morris-Stiff G; Teli M; Jardine N; Puntis MC
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):620-6. PubMed ID: 20007080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.
    Mann DV; Edwards R; Ho S; Lau WY; Glazer G
    Eur J Surg Oncol; 2000 Aug; 26(5):474-9. PubMed ID: 11016469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of elevated levels of serum CA 19-9.
    Pavai S; Yap SF
    Med J Malaysia; 2003 Dec; 58(5):667-72. PubMed ID: 15190651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA19-9 as a serum marker for poor prognosis in urothelial carcinoma.
    Suzuki K
    Urol Int; 2004; 73(4):357. PubMed ID: 15604583
    [No Abstract]   [Full Text] [Related]  

  • 18. Huge splenic epidermoid cyst with elevation of serum CA19-9 level.
    Matsumoto S; Mori T; Miyoshi J; Imoto Y; Shinomiya H; Wada S; Nakao T; Shinohara H; Yoshida S; Izumi K; Okazaki J; Muguruma N; Takayama T
    J Med Invest; 2015; 62(1-2):89-92. PubMed ID: 25817291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal: case of accidentally discovered splenic epidermoid cyst with serum CA19-9 elevation.
    Takagi K; Takayama T; Moriguchi M; Hasegawa H; Niide O; Kanamori N; Higaki T; Sugitani M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):231. PubMed ID: 24460837
    [No Abstract]   [Full Text] [Related]  

  • 20. Marked elevation of serum CA19-9 and stomach carcinoma.
    Horie Y; Matsui K; Shigoku A; Yukimasa A; Miura K; Hosoda A; Hamamoto T; Kawasaki H
    Oncology; 1998; 55(5):487-8. PubMed ID: 9732230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.